EICHOR
● Active Not Recruiting
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
Condition: Multiple Myeloma · Sponsor: Kite, A Gilead Company
About this study
The goal of this study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, including an anti-CD38 monoclonal antibody and an immunomodulatory drug. The primary objective of this study is to compare the efficacy of anitocabtagene autoleucel versus SOCT in participants with RRMM.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (117)
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | — |
| Mayo Clinic Hospital | Gilbert, Arizona, United States | — |
| City of Hope (City of Hope National Medical Center, City of Hope Medical Center) | Duarte, California, United States | — |
| USC/Norris Comprehensive Cancer Center | Los Angeles, California, United States | — |
| University of California Davis Comprehensive Cancer Center | Sacramento, California, United States | — |
| UC San Diego Moores Cancer Center | San Diego, California, United States | — |
| UCLA Hematology/Oncology (Bowyer Infusion Clinic) | Santa Monica, California, United States | — |
| Stanford Cancer Institute | Stanford, California, United States | — |
| Colorado Blood Cancer Institute | Denver, Colorado, United States | — |
| Sylvester Comprehensive Cancer Center | Coral Gables, Florida, United States | — |
| Mayo Clinic | Jacksonville, Florida, United States | — |
| Moffitt Cancer Center | Tampa, Florida, United States | — |
+ 105 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06413498